Skip to main content
logo
Pure Biologics S.A. (WSE:PUR)
Poland flag Poland · Delayed Price · Currency is PLN
2.140
-0.020 (-0.93%)
Jul 24, 2026, 5:03 PM CET

Pure Biologics Financials Overview

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.660.25
Revenue Growth
----160.63%-55.59%
Gross Profit
-0.03-0.03-0.05-0.06-5.41-4.03
Operating Income
-6.64-5.74-12.38-7.54-24.68-10.49
Net Income
-10.73-9.82-19.44-35.69-25.6-11.77
Earnings Per Share
-1.57-1.99-5.58-11.19-11.36-5.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.020.010.313.617.1832.93
Total Debt
16.4516.0114.0612.942.863.11
Net Cash (Debt)
-15.42-16-13.75-9.334.3229.82
Net Cash Growth
-----85.52%654.64%
Net Cash Per Share
-2.26-3.25-3.94-2.931.9213.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.63-6.25-10.83-23.26-17.39-24.04
Capital Expenditures
----0.18-5.76-0.67
Free Cash Flow
-8.63-6.25-10.83-23.44-23.15-24.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-----3728.40%-4129.13%
Pretax Margin
-----3867.52%-4631.89%
Profit Margin
-----3867.52%-4631.89%
FCF Margin
-----3496.22%-9727.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----78.31690.40